17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus

      research-article
      1 , 2 , , 3
      Virology
      Published by Elsevier Inc.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intracellular events in the synthesis, glycosylation, and transport of the lymphocytic choriomeningitis virus (LCMV) glycoproteins have been examined. We have shown by N-glycanase digestion that LCMV strain Arm-4 bears five oligosaccharides on GP-1 and two on GP-2. By pulse-chase labeling experiments in the presence of drugs which inhibit N-linked oligosaccharide addition and processing we demonstrate that addition of high mannose precursor oligosaccharides is necessary for transport and cleavage of the viral GP-C glycoprotein. Moreover, in the presence of tunicamycin which inhibits en bloc addition of these mannose-rich side chains, virus budding was substantially decreased and infectious virions were reduced by more than 1000-fold in the supernatant medium. Incubation in the presence of castantospermine, which permits addition of oligomannosyl-rich chains but blocks further processing, restored transport and cleavage of GP-C and maturation of virions. Finally, by temperature block experiments we have determined that maturation of GP-C oligosaccharides to an endoglycosidase H resistant form precedes cleavage to GP-1 and GP-2. The latter process is most likely to occur in the Golgi or post-Golgi compartment.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: not found
          • Article: not found

          Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

            The envelope protein of human immunodeficiency virus (HIV) is synthesized as a polyprotein (gp160) and cleaved intracellularly to a gp120-gp41 heterodimer. In this study, the tryptic-like endoproteolytic cleavage site was removed by site-directed mutagenesis and replaced with a chymotryptic-like site. The resultant mutant, RIP7/mut10, was found to be indistinguishable from wild-type HIV when analyzed at the level of proviral replication, RNA processing, protein expression, and viral assembly. However, the gp160 polyprotein was not cleaved and the mutated virions were biologically inactive, until and unless they were exposed to limiting concentrations of chymotrypsin. As is the case for other enveloped mammalian viruses, endoproteolytic cleavage of the HIV envelope protein and release of a unique hydrophobic domain appear to be necessary for the full expression of viral infectivity.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains.

              A D Elbein (1986)
                Bookmark

                Author and article information

                Journal
                Virology
                Virology
                Virology
                Published by Elsevier Inc.
                0042-6822
                1096-0341
                23 February 2004
                July 1990
                23 February 2004
                : 177
                : 1
                : 175-183
                Affiliations
                Department of Neuropharmacology, Research Institute of Scripps Clinic, La Jolla, California 92037, USA
                Author notes
                [3 ]To whom requests for reprints should be addressed at IMM5, 10666 N. Torrey Pines Road, La Jolla, CA 92037.
                [1]

                Present address: Department of Microbiology and Immunology, School of Medicine, University of Ottawa, Ottawa, Canada K1 H 8M5.

                [2]

                Department of Immunology, Research Institute of Scripps Clinic.

                Article
                0042-6822(90)90471-3
                10.1016/0042-6822(90)90471-3
                7130728
                2141203
                87df6769-4302-4bbe-b511-a35bcb015a93
                Copyright © 1990 Published by Elsevier Inc.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 25 April 1989
                : 14 March 1990
                Categories
                Article

                Microbiology & Virology
                Microbiology & Virology

                Comments

                Comment on this article